TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15816887

Group type: EXPERIMENTAL
Intervention: Ganciclovir prophylaxis
Number of subjects: 352

Group type: COMPARATOR
Intervention: Valganciclovir prophylaxis
Number of subjects: 352
Study: 11934908

Group type: EXPERIMENTAL
Intervention: Dowsing with Bryonia 12c potency
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 10224805

Group type: EXPERIMENTAL
Intervention: Oral administration of 10 mg dydrogesterone twice daily
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Intramuscular HCG administration 1500 IU every 4 days and 10 mg dydrogesterone twice daily
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 7972382

Group type: EXPERIMENTAL
Intervention: Topical application of broad-spectrum sunscreens with low SPF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical application of broad-spectrum sunscreens with increasing SPF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Broad-spectrum, highly protective sunscreens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Theoretical estimation of cis-UCA distribution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elimination of cis-UCA from the stratum corneum
Number of subjects: 0
Study: 2524407

Group type: EXPERIMENTAL
Intervention: INTERCEED(TC7)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control (untreated sidewall)
Number of subjects: 74
Study: 29549104

Group type: EXPERIMENTAL
Intervention: 0.9 mg of 0.1% E2 gel per day
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 1.8 mg of 0.1% E2 gel per day
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Transdermal E2 treatment
Number of subjects: 37
Study: 28781213

Group type: EXPERIMENTAL
Intervention: Testosterone Replacement Therapy (TRT)
Number of subjects: 999

Group type: COMPARATOR
Intervention: Not on TRT (untreated patients)
Number of subjects: 999
Study: 25407693

Group type: EXPERIMENTAL
Intervention: Structured educational intervention (two 3-hour schooling modules of group education)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Standard auto-injector training (control group)
Number of subjects: 193
Study: 23186730

Group type: EXPERIMENTAL
Intervention: Aerobic dance classes (2 classes per week) and 30 minutes of daily self-imposed physical activity for 12 weeks
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no aerobic dance intervention)
Number of subjects: 62
Study: 21195382

Group type: EXPERIMENTAL
Intervention: Oral doxycycline plus metronidazole
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: COMPARATOR
Intervention: No treatment (observational cohort with additional 75 cases)
Number of subjects: 56
Study: 18499950

Group type: EXPERIMENTAL
Intervention: Preoperative education and physical therapy (1 appointment with physiatrist, 2 practical classes with physiotherapist)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Preoperative education and physical therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no preoperative education and physical therapy)
Number of subjects: 45
Study: 16567641

Group type: EXPERIMENTAL
Intervention: Cortisone (25 mg) administered orally 1 h before a socio-evaluative stressor
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cortisol (10 mg), repeated oral administration 1 h before exposure to a spider photograph
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 14672103

Group type: EXPERIMENTAL
Intervention: Wearing a lucky garment, taking a test-preparation course, staying up late
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presentation of liquids (one trained as causal)
Number of subjects: 0
Study: 10746528

Group type: EXPERIMENTAL
Intervention: Combined lumbar and sacral plexus block (30 mL lidocaine 1.33% with epinephrine for posterior lumbar plexus block, 10 mL same mixture for parasacral block, and 5 mL lidocaine 1% for iliac crest block)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Plain bupivacaine spinal anesthesia (3 mL 0.5% plain bupivacaine)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combined lumbar and sacral plexus block
Number of subjects: 29

Group type: COMPARATOR
Intervention: Plain bupivacaine spinal anesthesia
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combined lumbar and sacral plexus block and plain bupivacaine spinal anesthesia
Number of subjects: 29
Study: 8909433

Group type: EXPERIMENTAL
Intervention: BCAA (L-leucine 12 g, L-isoleucine 8 g, L-valine 6.4 g daily)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: L-threonine (4 g daily) with pyridoxal phosphate (160 mg daily)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 8265272

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (NS)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Baseline
Number of subjects: 12
Study: 3492413

Group type: EXPERIMENTAL
Intervention: Sucralfate 1.0 g qid
Number of subjects: 24

Group type: COMPARATOR
Intervention: Aspirin 2.5 g
Number of subjects: 24
Study: 31977558

Group type: EXPERIMENTAL
Intervention: 3D printing group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional method group
Number of subjects: 40
Study: 30467685

Group type: EXPERIMENTAL
Intervention: Combined spironolactone (25 mg/d) plus vitamin E (400 IU/d) for 52 weeks
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU/d) for 52 weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 55
Study: 27639137

Group type: EXPERIMENTAL
Intervention: Extended-release naproxen sodium 660 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate-release naproxen sodium 220 mg twice daily (440 mg initially, followed by 220 mg 12 hours later)
Number of subjects: 0
Study: 24415649

Group type: EXPERIMENTAL
Intervention: Horse antithymocyte globulin (h‐ATG) plus cyclosporine (CsA)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Cyclophosphamide/CsA (initial therapy)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Overall survival for the cohort
Number of subjects: 25
Study: 23134959

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with fentanyl (Group DF)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fentanyl (Group F)
Number of subjects: 80
Study: 20837797

Group type: EXPERIMENTAL
Intervention: Standardized stereoscopic fundus photographs
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Standardized fluorescein angiograms
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Temporal reproducibility
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Contemporaneous reproducibility
Number of subjects: 60
Study: 18363528

Group type: EXPERIMENTAL
Intervention: Medication reconciliation program (113 patients)
Number of subjects: 521

Group type: COMPARATOR
Intervention: Usual care control group (408 patients)
Number of subjects: 521
Study: 15821181

Group type: EXPERIMENTAL
Intervention: Fish oil (2 g/d)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Soy oil (2 g/d)
Number of subjects: 58
Study: 12898858

Group type: EXPERIMENTAL
Intervention: AGT gene polymorphism (M235T)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: AT1R gene polymorphism (A1166C)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: C allele of A1166C polymorphism
Number of subjects: 90

Group type: COMPARATOR
Intervention: ACE gene polymorphism (insertion/deletion)
Number of subjects: 90
Study: 10716040

Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine administered in combination with chlorpheniramine maleate at 2200 hours
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine administered in combination with chlorpheniramine maleate at 1000 hours
Number of subjects: 4
Study: 8538480

Group type: EXPERIMENTAL
Intervention: 2 mg oestradiol valerate (days 1‐21) + 1 mg cyproterone acetate (days 12‐21)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transdermal 17 beta‐oestradiol (50 micrograms twice weekly during three weeks) + 20 mg dydrogesterone (days 12‐21)
Number of subjects: 60
Study: 1779005

Group type: EXPERIMENTAL
Intervention: Gentamicin iontophoresis plus dressing changes every 6 hours and cleaning
Number of subjects: 15

Group type: COMPARATOR
Intervention: Routine care alone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Gentamicin iontophoresis
Number of subjects: 15
Study: 7368149

Group type: EXPERIMENTAL
Intervention: Subcutaneous calcium heparin (2,500 u pre‐operatively then 5,000 u 12‐hourly for 7 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline injections (control group)
Number of subjects: 24
Study: 31989330

Group type: EXPERIMENTAL
Intervention: Newly developed extended-release HPMC niacin formulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Originator extended-release niacin product
Number of subjects: 0
Study: 30297210

Group type: EXPERIMENTAL
Intervention: Naftazone 160 mg/day
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 28662378

Group type: EXPERIMENTAL
Intervention: Flexible lightwand (Group L)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional ETT withdrawal (Group W)
Number of subjects: 60
Study: 26795957

Group type: EXPERIMENTAL
Intervention: Semiannual fluoride varnish applications every 6 months
Number of subjects: 3403

Group type: COMPARATOR
Intervention: Standardized oral health program once yearly between 1 and 3 years of age (Control)
Number of subjects: 3403
Study: 24115314

Group type: COMPARATOR
Intervention: Bolus calculator and wireless communication between insulin pump and blood glucose metre (Group A)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Bolus calculator without communication (Group B)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Control group (Group C)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Bolus calculator function (Group A)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Bolus calculator function (Group B)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Glycated haemoglobin levels (Group A)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Post-prandial glycaemia, body mass index-SD score, insulin/kg/24 h (Group A)
Number of subjects: 156
Study: 21499896

Group type: EXPERIMENTAL
Intervention: Patupilone combined with midazolam 4 mg PO (days 1 and 29)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Patupilone combined with omeprazole 40 mg PO (days 1 and 29)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Patupilone
Number of subjects: 46
Study: 19700170

Group type: EXPERIMENTAL
Intervention: Class III antiarrhythmic drugs (AADs)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Not taking class III antiarrhythmic drugs (AADs)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Increased intracardiac QT variability
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Intracardiac QT variability index
Number of subjects: 500
Study: 17915799

Group type: EXPERIMENTAL
Intervention: Sodium feredetate (33 mg elemental iron) with vitamin B12 (15 microg) and folic acid (1.5 mg) administered twice a day (Group A)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Sodium feredetate (66 mg elemental iron) with vitamin B12 (15 microg) and folic acid (1.5 mg) administered twice a day (Group B)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Ferrous fumarate (100 mg elemental iron) with vitamin B12 (15 microg) and folic acid (1.5 mg) administered twice a day (Group C)
Number of subjects: 48
Study: 15205383

Group type: EXPERIMENTAL
Intervention: Single oral dose of [(14)C]capravirine (1400 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Multiple oral doses of ritonavir (100 mg) followed by a single oral dose of [(14)C]capravirine (1400 mg)
Number of subjects: 10
Study: 11284795

Group type: EXPERIMENTAL
Intervention: Allergen-specific immunotherapy (SIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 9222182

Group type: EXPERIMENTAL
Intervention: OPC-14117 240 mg per day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8165451

Group type: EXPERIMENTAL
Intervention: Modern dentinal adhesive (Prisma Universal Bond 3) without cavity liner
Number of subjects: 60

Group type: COMPARATOR
Intervention: Light-cured glass-ionomer liner with modern dentinal adhesive
Number of subjects: 60
Study: 3662059

Group type: EXPERIMENTAL
Intervention: LE + NaHCO3 (0.1 mEq/ml anesthetic solution)
Number of subjects: 21

Group type: COMPARATOR
Intervention: LE alone
Number of subjects: 21
Study: 29766318

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate 50 mg tablet once daily
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 94
Study: 27805026

Group type: COMPARATOR
Intervention: AERAS-402 vaccine
Number of subjects: 0
Study: 24974961

Group type: EXPERIMENTAL
Intervention: Suprasacral technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lumbar plexus block
Number of subjects: 20
Study: 22776761

Group type: EXPERIMENTAL
Intervention: Tele-CP
Number of subjects: 67

Group type: COMPARATOR
Intervention: In-Person CP
Number of subjects: 67
Study: 20686011

Group type: EXPERIMENTAL
Intervention: Tables
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Pictographs
Number of subjects: 408

Group type: COMPARATOR
Intervention: Standard text
Number of subjects: 408
Study: 18392313

Group type: EXPERIMENTAL
Intervention: Steamed buns (bao)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control food
Number of subjects: 0
Study: 16192545

Group type: EXPERIMENTAL
Intervention: CSE using bupivacaine 0.5% for spinal anesthesia and ropivacaine 0.2% with 0.5 microg/mL of sufentanil for postoperative epidural analgesia (CSE; n = 8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: General anesthesia followed by IV patient‐controlled analgesia with piritramide (control; n = 8)
Number of subjects: 16
Study: 12578921

Group type: EXPERIMENTAL
Intervention: Spike-triggered fMRI during silent reading
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Comparison of left central sulcal patterns in subjects with RE
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Spike activity during reading
Number of subjects: 2
Study: 10480779

Group type: EXPERIMENTAL
Intervention: Impaired Glucose Tolerance (IGT) group
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Entire group
Number of subjects: 77

Group type: COMPARATOR
Intervention: Normal Glucose Tolerance (NGT) group
Number of subjects: 77
Study: 8608877

Group type: EXPERIMENTAL
Intervention: Mesalamine (Pentasa) 4 g . day(‐1)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 1765056

Group type: EXPERIMENTAL
Intervention: 50% VO2max
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 70% VO2max
Number of subjects: 12
Study: 6604081

Group type: EXPERIMENTAL
Intervention: Dazoxiben (100 mg orally three times once every 4 hr)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 17
Study: 31775405

Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KT)
Number of subjects: 72
Study: 29049415

Group type: EXPERIMENTAL
Intervention: Diacerein
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 27574399

Group type: EXPERIMENTAL
Intervention: FDC therapy (40 mg olmesartan medoxomil, 20 mg rosuvastatin)
Number of subjects: 162

Group type: COMPARATOR
Intervention: olmesartan medoxomil (40 mg)
Number of subjects: 162

Group type: COMPARATOR
Intervention: rosuvastatin (20 mg)
Number of subjects: 162
Study: 25048851

Group type: EXPERIMENTAL
Intervention: Fosfomycin (2 g/6 hours IV) plus Imipenem (1 g/6 hours IV)
Number of subjects: 16
Study: 22867112

Group type: EXPERIMENTAL
Intervention: Pulmonary Hypertension (PH)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Albumin level
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Extracellular water
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Left atrium enlargement
Number of subjects: 75
Study: 19573818

Group type: EXPERIMENTAL
Intervention: Laparoscopic myomectomy (LPS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Minilaparotomic myomectomy (MLPT)
Number of subjects: 80
Study: 17610432

Group type: EXPERIMENTAL
Intervention: Intervention group (specific intervention details not provided)
Number of subjects: 479

Group type: COMPARATOR
Intervention: Control group (specific control details not provided)
Number of subjects: 479
Study: 15355139

Group type: EXPERIMENTAL
Intervention: High-OSPAN individuals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-OSPAN individuals
Number of subjects: 0
Study: 11354529

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (200 mg per week)
Number of subjects: 16
Study: 10052233

Group type: EXPERIMENTAL
Intervention: Valgus high tibial osteotomy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Walking with the limb extrarotated
Number of subjects: 21
Study: 8028614

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (20 mg twice daily for four weeks)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo (for four weeks)
Number of subjects: 163
Study: 2733080

Group type: EXPERIMENTAL
Intervention: 200 ml of a 10% glucose polymer solution at 20 min intervals during exercise (CHO)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sweet placebo (CON)
Number of subjects: 9
Study: 1221326

Group type: EXPERIMENTAL
Intervention: 5-drug therapy (5 FU, methotrexate, vincristine, cyclophosphamide, and prednisone)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 4-drug therapy (5 FU, methotrexate, vincristine, cyclophosphamide)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 5-drug therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: 4-drug therapy
Number of subjects: 100
Study: 29443537

Group type: EXPERIMENTAL
Intervention: Insertion-preserved hamstring tendon graft
Number of subjects: 45

Group type: COMPARATOR
Intervention: Insertion-detached hamstring tendon graft
Number of subjects: 45
Study: 27931556

Group type: EXPERIMENTAL
Intervention: NPHW intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study: 24644541

Group type: EXPERIMENTAL
Intervention: Weekly vitamin D supplementation (cholecalciferol; 50,000 units for 12 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 60
Study: 22407256

Group type: EXPERIMENTAL
Intervention: Fenestrated lenses with three 0.20 mm fenestrations at 120° intervals
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-fenestrated lenses
Number of subjects: 22
Study: 20510665

Group type: EXPERIMENTAL
Intervention: Prenatal exposure to beta-blocking agents
Number of subjects: 1037

Group type: EXPERIMENTAL
Intervention: Prenatal exposure to folic acid
Number of subjects: 1037

Group type: COMPARATOR
Intervention: Iron supplementation, antiemetics, analgesics, antibiotics, or any other main ATC group
Number of subjects: 1037
Study: 18179323

Group type: EXPERIMENTAL
Intervention: Rumination
Number of subjects: 2

Group type: COMPARATOR
Intervention: Reappraisal
Number of subjects: 2
Study: 16707912

Group type: EXPERIMENTAL
Intervention: Insulin infusion (433 +/- 40 pmol/l)
Number of subjects: 16

Group type: COMPARATOR
Intervention: No insulin (serum insulin levels suppressed at 14 +/- 1 pmol/l)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Insulin infusion
Number of subjects: 16

Group type: COMPARATOR
Intervention: No insulin
Number of subjects: 16
Study: 14629524

Group type: EXPERIMENTAL
Intervention: 1 mL 25% sucrose
Number of subjects: 128

Group type: COMPARATOR
Intervention: 1 mL water (placebo)
Number of subjects: 128
Study: 10797125

Group type: EXPERIMENTAL
Intervention: Combined estradiol-norethindrone (OC E+P)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Progestin-only oral contraceptive (OC P)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Follicular phase
Number of subjects: 8

Group type: COMPARATOR
Intervention: Luteal phase
Number of subjects: 8
Study: 8890423

Group type: EXPERIMENTAL
Intervention: Warm CO2 gas insufflation (group B, n = 53)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Cold CO2 gas insufflation (control group A, n = 50)
Number of subjects: 103
Study: 1702696

Group type: EXPERIMENTAL
Intervention: 3% dextran-60 in Ringer's lactate (D60)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ringer's lactate (RL)
Number of subjects: 20
Study: 6873133

Group type: EXPERIMENTAL
Intervention: Indapamide 2.5 mg/d
Number of subjects: 10
Study: 31258136

Group type: EXPERIMENTAL
Intervention: 10-day bismuth-containing quadruple therapy (BQT)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: 14-day bismuth-containing quadruple therapy (BQT)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: 10-day moxifloxacin-bismuth-combined treatment (MBCT)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: 14-day moxifloxacin-bismuth-combined treatment (MBCT)
Number of subjects: 216
Study: 28900759

Group type: EXPERIMENTAL
Intervention: Sevelamer carbonate (SC)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 27432383

Group type: EXPERIMENTAL
Intervention: Triple therapy with vonoprazan-amoxicillin-clarithromycin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Triple therapy with vonoprazan-amoxicillin-metronidazole
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (single therapy)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 24
Study: 24471366

Group type: EXPERIMENTAL
Intervention: Training offered and received
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not offered training)
Number of subjects: 0
Study: 22892157

Group type: EXPERIMENTAL
Intervention: ERN (2 g/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: P‐OM3 (4 g/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination treatment (ERN + P‐OM3)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dual placebo
Number of subjects: 60
Study: 20462054

Group type: EXPERIMENTAL
Intervention: Shenqi Fuzheng Injection (SFI) plus chemotherapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Chemotherapy only (Control)
Number of subjects: 80
Study: 18260838

Group type: EXPERIMENTAL
Intervention: Indapamide retard 1.5 mg
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg
Number of subjects: 76